These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 19026699

  • 1. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
    Inada Y, Ikeda K, Tojo K, Sakamoto M, Takada Y, Tajima N.
    Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
    [Abstract] [Full Text] [Related]

  • 2. Regulation of urocortin I and its related peptide urocortin II by inflammatory and oxidative stresses in HL-1 cardiomyocytes.
    Ikeda K, Tojo K, Inada Y, Takada Y, Sakamoto M, Lam M, Claycomb WC, Tajima N.
    J Mol Endocrinol; 2009 Jun; 42(6):479-89. PubMed ID: 19318426
    [Abstract] [Full Text] [Related]

  • 3. Differential regulation of urocortins1-3 mRNA in human umbilical vein endothelial cells.
    Kageyama K, Hanada K, Suda T.
    Regul Pept; 2009 Jun 05; 155(1-3):131-8. PubMed ID: 19254747
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mediation of burn-induced hypermetabolism by CRF receptor-2 activity.
    Chance WT, Dayal R, Friend LA, Thomas I, Sheriff S.
    Life Sci; 2007 Feb 20; 80(11):1064-72. PubMed ID: 17222429
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
    Bittencourt JC, Vaughan J, Arias C, Rissman RA, Vale WW, Sawchenko PE.
    J Comp Neurol; 1999 Dec 20; 415(3):285-312. PubMed ID: 10553117
    [Abstract] [Full Text] [Related]

  • 8. Regulation of corticotropin-releasing factor receptor type 2beta mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells.
    Kageyama K, Gaudriault GE, Suda T, Vale WW.
    Cell Signal; 2003 Jan 20; 15(1):17-25. PubMed ID: 12401516
    [Abstract] [Full Text] [Related]

  • 9. Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach: protective biological role by inhibition of apoptosis.
    Chatzaki E, Lambropoulou M, Constantinidis TC, Papadopoulos N, Taché Y, Minopoulos G, Grigoriadis DE.
    J Cell Physiol; 2006 Dec 20; 209(3):905-11. PubMed ID: 16972272
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Urocortin expression is downregulated in human endometrial carcinoma.
    Florio P, De Falco G, Leucci E, Torricelli M, Torres PB, Toti P, Dell'Anna A, Tiso E, Santopietro R, Leoncini L, Petraglia F.
    J Endocrinol; 2006 Jul 20; 190(1):99-105. PubMed ID: 16837614
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of corticotropin-releasing factor1 receptor expression by stress and agonist treatments in brain and cultured cells.
    Iredale PA, Terwilliger R, Widnell KL, Nestler EJ, Duman RS.
    Mol Pharmacol; 1996 Nov 20; 50(5):1103-10. PubMed ID: 8913341
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
    Hashimoto K, Nishiyama M, Tanaka Y, Noguchi T, Asaba K, Hossein PN, Nishioka T, Makino S.
    Peptides; 2004 Oct 20; 25(10):1711-21. PubMed ID: 15476938
    [Abstract] [Full Text] [Related]

  • 18. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
    Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H.
    J Clin Endocrinol Metab; 2002 Jan 20; 87(1):340-6. PubMed ID: 11788672
    [Abstract] [Full Text] [Related]

  • 19. Regulation of corticotropin-releasing factor receptor type 2beta messenger ribonucleic acid by interleukin-1beta in rat vascular smooth muscle cells.
    Kageyama K, Suda T.
    Neuroimmunomodulation; 2001 Jan 20; 9(6):326-32. PubMed ID: 12045360
    [Abstract] [Full Text] [Related]

  • 20. Modulation of corticotropin-releasing hormone type 2 receptor and urocortin 1 and urocortin 2 mRNA expression in the cardiovascular system of prairie voles following acute or chronic stress.
    Pournajafi-Nazarloo H, Partoo L, Sanzenbacher L, Azizi F, Carter CS.
    Neuroendocrinology; 2007 Jan 20; 86(1):17-25. PubMed ID: 17551267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.